Skip to content Skip to navigation

Biologic and Materials Sciences and Division of Prosthodontics

Drach Lab Recent Publications

Return to Drach Lab

 

Review Chapter

Biron, K.K., K.S. Gudmundsson and J.C. Drach.  Benzimidazole ribonucleosides:  Novel drug candidates for the prevention and treatment of cytomegalovirus diseases.  In “Antiviral Drugs: From Basic Discovery Through Clinical Trials”; ed. by W.M. Kazmierski, John Wiley & Sons, Inc., Hoboken, NJ, 2011, pp. 417-433.

 

Original Research Publications

Zhou, S., J.C. Drach, M.N. Prichardand J. Zemlicka.  (Z)- and (E)-2-(1,2-Dihydroxyethyl)methylene-cyclopropane Analogues of 2´-Deoxyadenosine and 2´-Deoxyguanosine.  Synthesis of All Stereoisomers, Absolute Configuration and Antiviral Activity.  J. Med. Chem. 52: 3397-3407, 2009.

Li, C., B.G. Gentry, J.C. Drach, and J. Zemlicka.Synthesis and Enantioselectivity of Cyclopropavir Phosphates for Cellular GMP Kinase.  Nucleosides, Nucleotides, & Nucleic Acids 28: 795-808, 2009.

Wu, Z., J.C. Drach, M.N. Prichard, M. Yanachkova, I. Yanachkov, T.L. Bowlin, and J. Zemlicka.  L-Valine ester of cyclopropavir: a new antiviral prodrug.  Antiviral Chem. & Chemother. 20: 37-46, 2009.

Hwang, J.-S., R. Schilf, J.C. Drach, L.B. Townsend,and E. Bogner.  Susceptibilities of HCMV clinical isolates and other herpesviruses to new acetylated, tetrahalogenated benzimidazole D-ribonucleosides.  Antimicrob. Agents Chemother., 53: 5095–5101 2009.

Ptak, R.G., B.G. Gentry, T.L. Hartman, K.M. Watson, M.C. Osterling, R.W. Buckheit, Jr., L.B. Townsend and J.C. Drach.  Inhibition of Human Immunodeficiency Virus Type 1 by Triciribine Involves the Accessory Protein Nef.  Antimicrob. Agents Chemother., 54: 1512-1519, 2010.

Selvam, P., J.M. Breitenbach, K.Z. Borysko, and J.C. Drach.  Synthesis, antiviral activity, and cytotoxicity of some novel 2-phenyl-3-disubstituted quinazolin-4(3h)-ones.  Internat. J. Drug Design & Discovery, 1: 149-154, 2010.

Gentry, B.J., J.P. Kamil, D.M. Coen, J. Zemlicka, and J.C. Drach.  Stereoselective Phosphorylation of Cyclopropavirby pUL97 and CompetitiveInhibition by Maribavir. Antimicrob. Agents Chemother., 54: 3093–3098,2010.

Selvam, P., J.M. Breitenbach, K.Z. Borysko, and J.C. Drach.  Synthesis, Anti-HSV Activity, and Cytotoxicity of leaf extract ofmorinda citrifoliaNoni Journal of Clinical Res., 1:2-,2010.

Gentry, B.G., S.N. Gentry, T.L. Jackson, J. Zemlicka, and J.C. Drach.  Phosphorylationof Antiviral and Endogenous Nucleotides to Di- and Triphosphates by Guanosine Monophosphate Kinase.  Biochem. Pharmacol., 81: 43–49, 2011.

Prichard, M.N., S.L. Frederick, S. Daily, K.Z. Borysko, L.B. Townsend, J.C. Drach, and E.R. Kern.  Benzimidazole Analogs Inhibit Human Herpesvirus 6.  Antimicrob. Agents Chemother., 55: 2442–2445, 2011.

Peterson, L.W., J.-S. Kim, P. Kijek, S. Mitchell, J.M. Hilfinger, J.M. Breitenbach, K.Z. Borysko, J.C. Drach, B.A. Kashemirov, and C.E. McKenna.  Synthesis, transport and antiviral activity of Ala-Ser and Val-Ser prodrugs of cidofovir.  Bioorg. & Med. Chem. Lttrs., 21: 4045-4049, 2011.

Zakharova, V.M., M. Serpi, I.S. Krylov, L.W. Peterson, J.M. Breitenbach, K.Z. Borysko, J.C. Drach, M. Collins,J.M. Hilfinger, B.A. Kashemirov, and C.E. McKenna.  Tyrosine-Based 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine and -adenine ((S)-HPMPC and (S)-HPMPA) Prodrugs: Synthesis, Stability, Antiviral Activity and in Vivo Transport Studies. J. Med. Chem. 54: 5680-5693, 2011.

 

Return to Drach Lab